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External signals to activate cells often result with a change of the
cellular environment. To maintain viability cells must be able to
respond. This requires that cells must have the ability to change their
functions rapidly due to a given stimulus. Such cellular responsiveness
is accomplished through activation of signal transduction cascades
transmitting signals from the cell surface to internal cellular
machineries, often accompanied by signiﬁcant alterations of the
protein composition of cells. Such changes in cellular expression of
proteins can occur through a variety of mechanisms regulating
transcription, translation or post-translational modiﬁcations, but
recently growing evidence documented the importance of signal-
induced changes in the pattern of alternative splicing as an important
means to mediate biologically relevant cellular responses.
Activation of cells due to an external signal often results in up to a
100fold rise in the intracellular free Ca2+ concentration due to the
uptake of extracellular Ca2+ or the release of Ca2+ from intracellular
stores. These changes of the free Ca2+ concentration can cause
signiﬁcant oscillations of Ca2+ in the cytosol providing the possibility
of signal transduction for a number of different cellular activities such
as metabolism, protein phosphorylation and dephosphorylation,
fertilization, cell proliferation, division, gene expression and apopto-
sis, to name a few. Many of these functions are accomplished through
the interaction of Ca2+ with speciﬁc proteins resulting in modulations
of protein–protein interactions due to conformational changes of the
Ca2+-receptors. This review will focus on the increasing evidence for
an existing interface built up between the regulation of alternativell rights reserved.splicing and signal transduction pathways, with special emphasis on
calcium signaling.
2. Alternative splicing: general remarks
Alternative splicing is a dominant property of higher organisms to
produce multiple proteins from a single gene [1,2]. It has been
calculated that more than 40% of Drosophila genes [3] and over two
thirds of mouse or human genes [4] give rise to alternatively spliced
pre-mRNAs. These numbers might be still underestimated since in
recent years it became evident that many isoforms are either tissue
speciﬁc or are developmentally regulated [5]. Indeed, in 2 recent
publications byWang et al. [6] and by Pan et al. [7] it was documented
by analyzing different tissues and cell lines that about 95% of human
genes containing multiple exons undergo alternative splicing. How-
ever, the regulation of alternative splicing is still poorly understood.
For splicing to occur introns must be distinguished from exons, for
which a prerequisite is the pairing of the splice sites and their
recognition by the spliceosomewith high precision. In order to change
the content of exons of a givenmRNA thereby inﬂuencing the function
of the encoded protein in a speciﬁc cellular environment, alternative
splicing permits ﬂuctuation in the precise pairing of the splice sites
thus giving rise to alternative protein products. But how is this process
regulated? So far it seems clear that binding of spliceosomal subunits
to the pre-mRNA strongly inﬂuences the decision which splice sites
will be joined [1]. Such binding of spliceosomal subunits to the pre-
mRNA is a dynamic and highly ordered process to build the active
spliceosome which can be promoted or inhibited by splicing factors
binding to adjacent parts of the pre-mRNA thereby inﬂuencing the
selection of the splice sites.
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exonic and intronic regulatory sequences which bind speciﬁc factors
inﬂuencing splice-site selection as either exonic or intronic splicing
enhancers or silencers. These elements are required for the regulation
of alternative splicing [8–10].
Besides of constitutive exons which are always spliced into the
ﬁnal mRNA, several subgroups of alternative splicings have been
described: (1) cassette exons which are either included or excluded
from themRNA [11], or, in the case of multiple cassette exons, they are
mutually exclusive [12], i.e. the ﬁnal mRNA always includes one of
several possible exons; (2) 5′ splice site or (3) 3′ splice site selection.
3. Transcription and splicing
For a long time it has been assumed that transcription and pre-
mRNA splicing are independent processes until it became evident that
splicing and polyadenylation reactions are often coupled to transcrip-
tion [13,14], depending on the time RNA polymerase II needs to
synthesize the transcription unit and to release the nascent pre-mRNA
[15]. Considering the size of many genes with numerous introns of the
size of several kbs, cotranscriptional splicing of the pre-mRNA appears
to be a rational concept.
It is well documented that one of the consequences of elevated
calcium in the cell, especially in the nucleus, is the induction of gene
expression [16], due to Ca2+-dependent transcription factors such as
CREB [17–19], CREMτ [17,20], ATF-1 [21], SRF [22], ETS-1 [23,24]
which are among the best substrates for the Ca2+-calmodulin
dependent kinase IV (CaMKIV). CaMKIV which itself is induced by
the thyroid hormone T3 during neuronal development [25,26] has
been localized to the nucleus [17,27,28], and thus has direct access to
transcription factors to regulate their function in a Ca2+-dependent
manner such as CREB which was originally identiﬁed as a cAMP-
dependent transcription factor which could be activated by PKA-
dependent phosphorylation [29]. Since later studies provided evidence
that this transcription factor could also be activated in a Ca2+-
dependent manner [16,19] CREB now stands for cAMP/calcium-
responsive element binding protein which is activated due to
phosphorylation at Ser133 (for a review see [30]).
4. Ca2+ signaling and alternative splicing
Since Ca2+ is an important signal to induce transcription it is
perhaps not surprising if Ca2+ signaling is also involved in the
regulation of alternative splicing due to a possible coupling between
transcription and splicing as described before. In a number of papers
the group of Black provided evidence that the Ca2+-calmodulin
dependent kinase IV is directly involved in Ca2+-dependent regula-
tion of alternative splicing [31–33]. In 2001 Xie and Black [31]
provided evidence that CaMKIV suppresses the splicing of the STREX
exon of the calcium-activated potassium channel. This channel plays
an important role in shaping the action potential of excitable cells, and
its splicing pattern is highly regulated. Inclusion of the STREX exon
confers higher Ca2+ sensitivity to the calcium-binding domain of the
channel. By depolarizing GH3 pituitary cells it was noticed that
splicing of the STREX exon was reduced by 50% [31]. Since it is well
documented that cellular depolarization stimulates the activity of
calmodulin-dependent kinases and subsequently Ca2+-dependent
gene expression [34] Xie and Black showed in elegant experiments
[31] that only CaMKIV, but not CaMKI or II speciﬁcally decreased the
inclusion of the STREX exon into themRNA of the channel. The authors
identiﬁed a CaMKIV-responsive RNA element (CaRRE) mediating the
alternative splicing of the pre-mRNA. In later studies [32,33] Black and
his co-workers extended these observations and showed that the
alternative splicing of the STREX exon is also controlled in neurons by
the CAMKIV pathway by using a primary cerebellar neuron culture
[32]. In this study the authors identiﬁed a CaMKIV-dependentconsensus sequence (CACATNRTTAT) in a number of genes within
the human genome which responded to CAMKIV [32].
The plasma membrane calcium pump (PMCA) plays a key role in
regulating the intracellular Ca2+ concentration in eukaryotic cells
[35]. The enzyme which belongs to the P-type class of ion-
transporting ATPases [36,37] is ubiquitous, and its major regulating
activator is calmodulin due to direct interactionwith the pump [38]. In
mammals four different genes (PMCA 1–4) have been identiﬁed [35]
which can give rise to a plethora of different isoforms due to
alternative splicing (for review see [35,39,40]). PMCA 1 and 4 are
considered as housekeeping pumps since they can be found in all
tissues, whereas PMCA2 is mainly detected in brain and heart, PMCA3
in brain and skeletal muscles [35]. By determining the ﬁrst primary
structure of PMCA from human and rat sources [41,42] it became
evident that alternative splicing may play an important role in
establishing the diversity of PMCA isoforms. This became even more
obvious when Strehler et al. [43] analyzed one of the splice sites in
more detail.
To date it is well documented that supplementary exons of the 4
PMCA genes are alternatively transcribed in the proximity of the two
main regulatory domains of the PMCA ([39]; see Fig. 1). Of the two
regions of alternative splicing splice site A is located upstream of the
phospholipids binding domain [44] within the ﬁrst intracellular loop
of the calcium pump and downstream of a sequence interacting with
the C-terminal part of the calmodulin-binding domain [45], whereas
splice site C is found within the calmodulin-binding domain at the C-
terminal cytosolic tail of the protein thereby inﬂuencing the strength
of interaction between calmodulin and the calcium pump [39,40]. As
will be discussed below in more detail this diversity of spliced
isoforms not only inﬂuences the function of the enzyme severely by
interfering with two important regulatory sequences of the enzyme,
but also enables the protein to control Ca2+ homeostasis in a cell- and
tissue-speciﬁc manner.
5. Regulation of alternative splicing of PMCA isoforms
By comparing cDNA clones from a fetal skeletal muscle cDNA
library with a teratoma cDNA encoding the human plasma membrane
Ca2+ pump Strehler et al. [43] discovered that these clones contained
isoforms of PMCA with an insertion of a 154 base-pair exon which
could give rise to either 29, 38 or 51 amino acid insertions within the
calmodulin-binding domain (splice site C). These variations occurred
due to alternative splicing making differential use of two internal
“cryptic” donor splice sites. Isoforms containing either 87 bp (29
amino acids, isoform “c”) or 114 bp (38 amino acids, isoform “d”)
insertions did not change the reading framewhereas if the entire exon
of 154 bp was inserted (isoform “a”) the reading frame was changed
resulting in a pump protein with a shorter C-terminal amino acid
sequence due to an early stop codon (see Fig. 1). In isoform “b” the 154
bp exon is excluded. A similar complex pattern of alternative splicing
has later been described for all 4 PMCA genes of human [46] or rat
origin [47,48], not only for site “C”, but also for site “A” as mentioned
before (see Fig. 1).
In many different studies it has been documented that the
expression pattern of the different PMCA isoforms varies in different
tissues, and the expression of many of its splice variants is
developmentally regulated [46,49,50]. By far the highest diversity of
different isoforms can be found in the brain manifesting their cellular
and developmental speciﬁcity, but the mechanism behind the
regulation of the alternative splicing events of the different PMCAs
is poorly understood.
As can be noticed from Fig. 1 splicing at site “A” affects an exon of
either 39 nucleotides (nt; PMCA1), 42 nt (PMCA2,3) or 36 nt
(PMCA4). In all PMCAs this exon can be either inserted or excluded
from the mature mRNA. For PMCA2 the situation is more complex. As
shown in Fig. 1 site “A” of PMCA2 includes 3 exons of the size 33, 60
Fig. 1. Topology domains and splicing variants of the PMCA isoforms. The 10 putative transmembrane domains of the pump are numbered and indicated by red boxes. Splice sites “A”
(ﬁrst cytosolic loop) and “C” (C-terminal tail) are indicated by red arrows. Splice site “C” lies within the calmodulin-binding domain (yellow cylinder; deﬁned by the structural model
of CaM = calmodulin). The exon structure of the different regions affected by alternative splicing is shown for each of the 4 different PMCA genes. Constitutively spliced exons are
indicated as dark blue boxes, alternatively inserted exons are shown in light blue; the resulting splice variants are labeled by their lower case symbols, the positions of the translation
stop codons for each splice form are indicated by the corresponding capital letters. In PMCA3, splice variant “e” results from a read-through of the 154-nt exon into the following
intron (indicated as small open box). The sizes of alternatively spliced exons are given as nucleotide numbers. PL = phospholipid binding domain; P = location of the aspartyl-
phosphate formation. The Figure was adopted from Fig. 1 of chapter 7 by C. Ortega, S. Ortolano and E. Carafoli in: Calcium, a matter of life or death (J. Krebs and M. Michalak, eds.) pp.
179–197, published by Elsevier, Amsterdam, 2007; with permission from the publishers.
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respect to the discussion below only 2 splice variants are of interest
here: variant “w” which includes all 3 exons and variant “x” which
includes only the 42 nt exon (see Fig.1). In 1996 Zacharias and Strehler
[51] reported that by depolarizing IMR32 neuroblastoma cells
alternative splicing occurred at splice site A of PMCA 2 due to the
intracellular rise of Ca2+, i.e. next to PMCA2w also the variant “x”was
expressed. On the other hand, in non-perturbed cells the “x” variant of
splice site A could only be detected in PMCA1,3,4, whereas in PMCA2
only the “w” variant was expressed indicating cell-speciﬁc differences
in the splice variants of the different PMCAs. Next to PMCA2w which
was always expressed PMCA2x could be detected already after 1
minute of depolarizing the cells with a high concentration of KCl [51].
This expression of the splice variant PMCA2x was only induced by a
transient rise of intracellular Ca2+, i.e. in the presence of the calcium
chelator BAPTA the expression of PMCA2x was suppressed. Of further
interest was the notion that in the presence of a serine/threonine
kinase inhibitor the transient rise of intracellular Ca2+ did not induce
the PMCA2x splice variant [51] indicating that a kinase – possibly a
calcium-dependent kinase – played an important role by transmitting
this signal transduction pathway. In this context it is of interest that
phosphorylation/dephosphorylation is an essential mechanism forthe function of various spliceosomal proteins (for a recent review see
[52]).
A signiﬁcantly different splicing pattern of the PMCA isoforms was
reported by Guerini et al. [53]. These authors investigated the
expression of PMCAs in cerebellar granule neurons during differentia-
tion. By comparing synaptosomal preparations from cerebella of 3-
day-old with those from 3-week-old rats the authors found a marked
increase in the expression of all 4 PMCA proteins. Remarkable was the
ﬁnding that the increase in PMCA1 expression was mainly due to the
isoform PMCA1a (see Fig.1) which includes the 154 nt exonwithin the
calmodulin-binding domain at splice site “C” leading to a truncated
version of PMCA1 due to a frame shift of the reading frame. In contrast
to the observation made by Zacharias and Strehler [51] Guerini et al.
[53] did not observe a change of alternative splicing at site “A” after
depolarizing granule cells indicating cell-speciﬁc differences of Ca2+-
dependent regulation of alternative splicing of the different PMCA
isoforms. A further cell-speciﬁc difference between neuroblastoma
and cerebellar granule cells in culture was the notion that the Ca2+-
dependent induction of PMCA2x in neuroblastoma cells occurred
within minutes. This is in contrast to the much longer incubation time
of granule cells under membrane depolarizing conditions (obtained
by applying high KCl concentrations) to observe the isoform switch of
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downregulated by depolarizing conditions in cultured granule cells
even if it was clearly detectable in adult cerebellum indicating the
presence of PMCA4 in other cell types of the cerebellum [53]. These
changes in the expression of the different PMCAs and their isoforms
due to alternative splicing induced under prolonged depolarizing
conditions which led to morphological changes typical for mature
granular neurons was clearly a Ca2+-dependent process. Addition of
nifedipine, a speciﬁc inhibitor of L-type (Cav1) Ca2+-channels,
completely abolished both the up-regulation of the PMCA1a, 2 and 3
and the down-regulation of the PMCA4 isoforms. On the other hand,
the cytosolic Ca2+ could be also increased by applying N-methyl-D-
aspartic acid, an activator of glutamate-operated Ca2+ channels. Using
this protocol similar observations could be made with respect to the
expression pattern of PMCA isoforms during the differentiation
process of granular cells [53].
These changes in the expression pattern of PMCA during the
maturation process of the granular cells may reﬂect the demand of
speciﬁc functional aspects of the calcium pump. Of the 4 PMCA
isoforms PMCA2which is particularly abundant in brain has the highest
afﬁnity for calmodulin [54]. This could provide cells with the possibility
to respond with a higher sensitivity even at low Ca2+ concentrations.
On the other hand, Ca2+-dependent alternative splicing at site “C” (Fig.
1) generated PMCA1a, an isoformwith lower afﬁnity for calmodulin in
analogy to the well characterized PMCA4a isoform [55,56], but a higher
basal, e.g. calmodulin-independent activity [56]. Recently, Caride et al.
[57] studied in detail the difference in activation kinetics between
PMCA isoforms 4a and 4b. These authors made the interesting
observation that binding of calmodulin to PMCA4a is faster than to
PMCA4b even if the afﬁnity of calmodulin for PMCA4a is lower than for
4b. From this observation the authors concluded that the afﬁnity of the
calmodulin-binding domain for its receptor sites was higher for
PMCA4b than for 4a and therefore the binding kinetics of calmodulin
for PMCA4b was slower. As a consequence it can be envisioned that
PMCA4a is more efﬁcient than PMCA4b by reducing cytosolic Ca2+
concentrations after a spike. If similar conclusions can be drawn for
PMCA1a then the Ca2+-dependent up-regulation of the latter isoform
due to alternative splicing could confer to the maturating granular cells
a more effective protein with higher Ca2+-pumping capacity.
If the view is correct that granule cells have an advantage during
development and differentiation to increase the expression of the
spliced isoform PMCA1a, the question arises how the cells regulate
alternative splicing to select for the PMCA1a isoform (see Fig. 1). As
mentioned before Black and co-workers [31–33] provided evidence
that by depolarizing GH3 pituitary cells the rise of intracellular Ca2+
activated CaMKIV which through a CaMKIV-responsive element
(CaRRE) was able to suppress the STREX exon of the calcium-activated
potassium channel [31] or exon 21 of the NMDA receptor 1 in P19 cells
[33]. By screening the human genome the Lab of Black identiﬁed a
CaMKIV-dependent consensus sequence in a number of genes
including PMCA [33]. The CaRRE of PMCAwas described as CACATGTA
which corresponds exactly to a sequence of the second internal splice
donor site of exon 21 of PMCA1 [43]. Thus by depolarizing granular
cells activated CAMKIV could suppress splicing of exon 21 of PMCA1 at
the second cryptic splicing site by recognizing the CaRRE of that site. If
one assumes that secondary structure of the pre-mRNA also could
inﬂuence alternative splicing (for a recent review see [58]) one could
envision that CAMKIV could also suppress the ﬁrst internal splice site
of exon 21 of PMCA1 thereby enhancing the expression of the PMCA1a
isoform as detected in differentiating granular cells [53]. In this
context it is of interest to point out that CAMKIV is particularly
enriched in the granular cells of the cerebellum [30] which were the
primary cellular source to characterize the enzyme [59].
Furthermore it should be pointed out that by comparing the
primary structures of the different PMCA genes of human and rat
origin a CaRRE could be identiﬁed only within PMCA1 underlining theselectivity of the spliced isoform of PMCA1a. Since CaMKIV is a protein
kinase it now would be important to identify the target of
phosphorylation, possibly a spliceosomal protein which coordinates
the splicing event of PMCA1a.
6. RBM22, a regulator of alternative splicing, interacting with ALG-2
in a calcium-dependent manner
The calcium-binding protein ALG-2 was discovered by the group of
D'Adamio in 1992 [60]. ALG-2 belongs to the family of penta EF-hand
Ca2+-binding proteins [61], e.g. these proteins contain ﬁve EF-hand
domains. We and others reported on the intracellular distribution of
ALG-2 and provided evidence for a signiﬁcant nuclear concentration of
ALG-2 [62–64]. In order to evaluate the reason for the nuclear
translocation of the cytoplasmic protein ALG-2we undertook a detailed
screening for possible partners by using a yeast two-hybrid screening
with ALG-2 as bait [65]. We identiﬁed the RNA-binding protein RBM22
as a new target for the interaction with ALG-2. To conﬁrm such an
interaction between the two proteins in vivo we performed a detailed
study preparing ﬂuorescent constructs by using the monomeric red
ﬂuorescent protein (mRFP) to label ALG-2 and the enhanced green
ﬂuorescent protein (EGFP) to label RBM22 [65]. Confocal microscopy of
NIH 3T3 cells transfected with either the ALG-2 or RBM22 ﬂuorescent
expression constructs alone revealed that the majority of ALG-2 was
localized in the cytoplasm whereas RBM22 was located in the nucleus
[65]. In contrast, when cells were co-transfected with expression
vectors encoding both fusion proteins ALG-2 was now detected in the
nucleus indicating that RBM22 was instrumental for the translocation
of ALG-2 to the nucleus [65]. Similar ﬁndings have also beenmadewith
zebraﬁsh embryos during development [65]. The interaction between
RBM22 and ALG-2 seems to be Ca2+ dependent. If NIH 3T3 cells were
cotransfected with RBM22-EGFP and ALG-2-mRFP, the latter being the
double mutant E47Q, E114Q preventing Ca2+-binding at the high
afﬁnity Ca2+-binding sites 1 and 3 [66], ALG-2 concentration in the
nucleus was signiﬁcantly reduced (data not shown).
RBM22 is a highly conserved RNA-binding protein, human and
mouse homologues are identical proteins [65]. Next to the RNA-
binding domain it contains an unusual zinc ﬁnger of the type
Cx8Cx5Cx3H and 2 conserved sumoylation consensus sequences
(see [65] for details). RBM22 was identiﬁed by 2 Laboratories as an
auxiliary protein of the spliceosome of unknown function [67,68]. By a
genome wide screening to identify essential proteins involved in the
regulation of alternative splicing RBM22 was identiﬁed as one of the
essential regulators of alternative splicing of the complex Drosophila
gene Dscam [69], it also inﬂuenced the heart development of Droso-
phila [70], the development of zebraﬁsh [71] and it inﬂuenced the
regulation of the cell cycle in HeLa cells [72]. These ﬁndings underline
the important regulatory property of RBM22 and by interacting with
ALG-2 Ca2+-dependent signaling may inﬂuence alternative splicing
and cell division during development.
Spliceosomes are formed in a dynamic process on nascent pre-
mRNAs, and they disassemble after introns are excised and exons are
ligated. Spliceosomal components at rest and not engaged in splicing
accumulate in morphologically distinct structures such as interchro-
matin granule clusters or speckles [73,74]. Recent studies [75] seem to
indicate that modifying components of the spliceosome by the small
ubiquitin-like modulator protein (SUMO) may inﬂuence their locali-
zation to nuclear bodies like speckles. As shown in Fig. 2 if the wild
type protein RBM22 is labeled with GFP it distributes evenly over the
nucleus (Fig. 2A) reﬂecting its dynamic behaviour. However, if the
lysines of the 2 sumoylation consensus sites are mutated to arginines,
i.e. K170R and K324R, RBM22 seems to accumulate in speckle-like
structures (Fig. 2B). This results in a 2–3 times enlargement of those
structures indicating an interruption of the dynamic distribution of
RBM22 within the nucleus. This may prevent to execute its regulatory
role at the spliceosome. Similarly, it has been suggested that protein
Fig. 2. Nuclear images of transfected NIH 3T3 cells. Cells were transfected with expression vectors containing cDNA encoding EGFP constructs of either wild type RBM22 (RBM22-
EGFP; (A) or a double mutant of RBM22 replacing K170 and K324 by R to prevent sumoylation (B). Images were takenwith a ﬁlter for green ﬂuorescence (excitation at 488 nm). The
bar indicates 5 μm.
983J. Krebs / Biochimica et Biophysica Acta 1793 (2009) 979–984phosphorylation is an important mechanism to recruit splicing factors
from speckles for active sites of pre-mRNA splicing [76].
In conclusion, as outlined in the present review data are
accumulating to indicate an inﬂuence of Ca2+-signaling on the
regulation of alternative splicing either through a Ca2+-dependent
enzyme such as CaMKIV which may phosphorylate a spliceosomal
component thereby inﬂuencing the regulation of alternative splicing
or by interacting of a Ca2+-binding protein such as ALG-2 with a
regulatory component of the spliceosome such as RBM22. In the
future it will be important to characterize the targets by which Ca2+-
signaling could control the regulation of alternative splicing thereby
inﬂuencing basic cellular processes during development.
Acknowledgements
The continuous support of my colleagues Dr. Stefan Becker and,
especially, Dr. Christian Griesinger, Head of the NMR based Structural
Biology Department at the Max Planck Institute for Biophysical
Chemistry, Göttingen, Germany, is gratefully acknowledged.
Dr. Ernesto Carafoli is thanked for the permission to reproduce Fig. 1.
References
[1] D.L. Black, Mechanisms of alternative pre-messenger RNA splicing, Annu. Rev.
Biochem. 72 (2003) 291–336.
[2] B.J. Blencowe, Alternative splicing: new insights from global analyses, Cell 126
(2006) 37–47.
[3] V. Stolc, Z. Gauhar, C. Mason, G. Halasz, M.F. van Batenburg, S.A. Rifkin, S. Hua, T.
Herreman, W. Tongprasit, P.E. Barbano, H.J. Bussemaker, K.P. White, A gene
expression map for the euchromatic genome of Drosophila melanogaster, Science
306 (2004) 655–660.
[4] J.M. Johnson, J. Castle, P. Garrett-Engele, Z. Kan, P.M. Loerch, C.D. Armour, R.
Santos, E.E. Schadt, R. Stoughton, D.D. Shoemaker, Science 302 (2003)
2141–2144.
[5] A.J. Lopez, Alternative splicing of pre-mRNA: developmental consequences and
mechanisms of regulation, Annu. Rev. Genet. 32 (1998) 279–305.
[6] E.T. Wang, R. Sandberg, S. Luo, I. Khrebtukova, L. Zhang, C. Mayr, S.F. Kingsmore, G.
P. Schroth, C.B. Burge, Alternative isoform regulation in human tissue transcrip-
tomes, Nature 456 (2008) 470–476.
[7] Q. Pan, O. Shai, L.J. Lee, B.J. Frey, B.J. Blencowe, Deep surveying of alternative
splicing complexity in the human transcriptome by high-throughput sequencing,
Nat. Genet. 40 (2008) 1413–1415.
[8] J.F. Caceres, A.R. Kornblihtt, Alternative splicing: multiple control mechanisms and
involvement in human disease, Trends Genet. 18 (2002) 186–193.
[9] B.J. Blencowe, Exonic splicing enhancers: mechanism of action, diversity and role
in human genetic diseases, Trends Biochem. Sci. 25 (2000) 106–110.
[10] W.G. Fairbrother, R.F. Yeh, P.A. Sharp, C.B. Burge, Predictive identiﬁcation of exonic
splicing enhancers in human genes, Science 297 (2002) 1007–1013.
[11] A. Andreadis, M.E. Gallego, Nadal-Ginard, Generation of protein isoform diversity
by alternative splicing: mechanistic and biological implications, Annu. Rev. Cell
Biol. 3 (1987) 207–242.
[12] C.W. Smith, B. Nadal-Ginard, Mutually exclusive splicing of alpha-tropomyosinex-
ons enforced by an unusual lariat branch point location: implications for
constitutive splicing, Cell 56 (1989) 749–758.
[13] N.J. Proudfoot, A. Furger, M.J. Dye, Integrating mRNA processing with transcrip-
tion, Cell 108 (2002) 501–512.
[14] D.L. Bentley, Rules of engagement: cotranscriptional recruitment of pre-mRNA
processing factors, Curr. Opin. Cell Biol. 17 (2005) 251–256.[15] K.M. Neugebauer, On the importance of being cotranscriptional, J. Cell Sci. 115 (Pt.
20) (2002) 3865–3871.
[16] M. Sheng, G. McFadden, M.E. Greenberg, Membrane depolarization and calcium
induce c-fos transcription via phosphorylation of transcription factor CREB,
Neuron 4 (1990) 571–582.
[17] R.P. Matthews, C.R. Guthrie, L.M. Wailes, X. Zhao, A.R. Means, G.S. McKnight,
Calcium/calmodulin-dependent kinas types II and IV differentially regulate CREB-
dependent gene expression, Mol. Cell. Biol. 14 (1994) 6107–6116.
[18] H. Enslén, P. Sun, D. Brickey, S.H. Soderling, E. Klamo, T.R. Soderling, Characteriza-
tion of Ca2+/calmodulin-dependent protein kinase IV. Role in transcriptional
regulation, J. Biol. Chem. 269 (1994) 15520–15527.
[19] M. Sheng, M.E. Thompson, M.E. Greenberg, CREB: a Ca(2+)-regulated transcrip-
tion factor phosphorylated by calmodulin-dependent kinases, Science 252 (1991)
1427–1430.
[20] Z. Sun, P. Sassone-Corsi, A.R. Means, Calspermin gene transcription is regulated by
two cyclic AMP response elements contained in an alternative promoter in the
calmodulin kinase IV gene, Mol. Cell. Biol. 15 (1995) 561–571.
[21] P. Sun, L. Lou, R.A. Maurer, Regulation of activating transcription factor 1 and the
camp response element-binding protein by Ca2+/calmodulin-dependent protein
kinases type I, II, and IV, J. Biol. Chem. 271 (1996) 3066–3073.
[22] C.K. Miranti, D.D. Ginty, G. Huang, T. Chatila, M.E. Greenberg, Calcium activates
serum response factor-dependent transcription by a ras- and elk-1-independent
mechanism that involves a Ca2+/calmodulin-dependent kinase, Mol. Cell. Biol. 15
(1995) 3672–3684.
[23] P. Pognonec, K.E. Boulukos, J. Gesquiere, D. Stehelin, J. Ghysdael, Mitogenic
stimulation of thymocytes results in the calcium-dependent phosphorylation of
c-ets-1 proteins, EMBO J. 7 (1988) 977–983.
[24] C.L. Fisher, J. Ghysdael, J.C. Cambier, Ligation of membrane Ig leads to calcium-
mediated phosphorylation of the proto-oncogene, Ets-1, J. Immunol. 146 (1991)
1743–1749.
[25] J. Krebs, R.L. Means, P. Honegger, Induction of calmodulin kinase IV by the thyroid
hormone during the development of rat brain, J. Biol. Chem. 271 (1996)
11055–11058.
[26] Y.Y. Liu, G.A. Brent, A complex deoxyribonucleic acid response element in the rat
Ca2+/calmodulin-dependent protein kinase IV gene 5′-ﬂanking region mediates
thyroid hormone induction and chicken ovalbumin upstream promoter transcrip-
tion factor 1 repression, Mol. Endorinol. 16 (2002) 2439–2451.
[27] K.F. Jensen, C.A. Ohmstede, R.S. Fisher, N. Sahyoun, Nuclear and axonal localization
of Ca2+/calmodulin-dependent protein kinase type Gr in rat cerebellar cortex,
Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 2850–2853.
[28] H. Bito, K. Deisseroth, R.W. Tsien, CREB phosphorylation and dephosphorylation: a
Ca(2+)- and stimulus duration-dependent switch for hippocampal gene
expression, Cell 87 (1996) 1203–1214.
[29] G.A. Gonzalez, M.R. Montminy, Cyclic AMP stimulates somatostatin gene
transcription by phosphorylation of CREB at serine 133, Cell 59 (1989)
675–680.
[30] J. Krebs, Calmodulin-dependent protein kinase IV: regulation of function and
expression, Biochim. Biophys. Acta 1448 (1998) 183–189.
[31] J. Xie, D.L. Black, A CaMKIV responsive RNA element mediates depolarization-
induced alternative splicing in ion channels, Nature 410 (2001) 936–939.
[32] J. Xie, C. Jan, P. Stoilov, J. Park, D.L. Black, A consensus CaMKIV-responsive RNA
sequence mediates regulation of alternative exons in neurons, RNA 11 (2005)
1825–1834.
[33] J.A. Lee, Y. Xing, D. Nguyen, J. Xie, C.J. Lee, D.L. Black, Depolarization and
CaMKinase IV modulate NMDA receptor splicing through two essential RNA
elements, PLoS Biol. 5 (2007) e40 10.1371/journal.pbio.0050040.
[34] J. Colomer, A.R. Means, Physiological roles of the Ca2+/CaM-dependent protein
kinase cascade in health and disease, Subcell. Biochem. 45 (2007) 169–214.
[35] F. Di Leva, T. Domi, L. Fedrizzi, D. Lim, E. Carafoli, The plasma membrane Ca2+
ATPase of animal cells: Structure, function and regulation, Arch. Biochem. Biophys.
476 (2008) 65–74.
[36] P.L. Pedersen, E. Carafoli, Ion motive ATPases. I. Ubiquity, properties, and
signiﬁcance for cell function, Trends Biochem. Sci. 12 (1987) 146–150.
[37] P.L. Pedersen, E. Carafoli, Ion motive ATPases. II. Energy coupling and work output,
Trends Biochem. Sci. 12 (1987) 186–189.
984 J. Krebs / Biochimica et Biophysica Acta 1793 (2009) 979–984[38] P. James, M. Maeda, R. Fischer, A.K. Verma, J. Krebs, J.T. Penniston, E. Carafoli,
Identiﬁcation and primary structure of a calmodulin binding domain of the Ca2+
pump of human erythrocytes, J. Biol. Chem. 263 (1988) 2905–2910.
[39] E.E. Strehler, D.A. Zacharias, Role of alternative splicing in generating isoform
diversity among plasmamembrane calcium pumps, Physiol. Rev. 81 (2001) 21–50.
[40] M. Brini, Plasma membrane Ca(2+)-ATPase: from a housekeeping function to a
versatile signaling role, Pﬂugers Arch. (in press), doi:10.1007/s00424-008-0505-6.
[41] A.K. Verma, A.G. Filoteo, D.R. Stanford, E.R. Wieben, J.T. Penniston, E.E. Strehler, R.
Fischer, R. Heim, G. Vogel, S. Mathews, M.A. Strehler-Page, P. James, T. Vorherr, J.
Krebs, E. Carafoli, Complete primary structure of a human plasmamembrane Ca2+
pump, J. Biol. Chem. 263 (1988) 14152–14159.
[42] G.E. Shull, J. Greeb, Molecular cloning of two isoforms of the plasma membrane
Ca2+-transporting ATPase from rat brain. Structural and functional domains
exhibit similarity to Na+, K+ - and other cation transport ATPases, J. Biol. Chem.
263 (1988) 8646–8657.
[43] E.E. Strehler, M.A. Strehler-Page, G. Vogel, E. Carafoli, mRNAs for plasma
membrane calcium pump isoforms differing in their regulatory domain are
generated by alternative splicing that involves two internal donor sites in a single
exon, Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 6908–6912.
[44] E. Zvaritch, P. James, T. Vorherr, R. Falchetto, N. Modyanov, E. Carafoli, Mapping of
functional domains in the plasma membrane Ca2+ pump using trypsin
proteolysis, Biochemistry 29 (1990) 8070–8076.
[45] R. Falchetto, T. Vorherr, E. Carafoli, The calmodulin-binding site of the plasma
membrane Ca2+ pump interactr with the transduction domain of the enzyme,
Protein Sci. 1 (1992) 1613–1621.
[46] T.P. Stauffer, H. Hilﬁker, E. Carafoli, E.E. Strehler, Quantitative analysis of alternative
splicing options of human plasma membrane calcium pump genes, J. Biol. Chem.
268 (1993) 25993–26003.
[47] T.P. Keeton, S.E. Burk, G.E. Shull, Alternative splicing of exons encoding the
calmodulin-binding domains and C termini of plasma membrane Ca(2+)-ATPase
isoforms 1, 2, 3, and 4, J. Biol. Chem. 268 (1993) 2740–2748.
[48] T.P. Keeton, G.E. Shull, Primary structure of rat plasma membrane Ca(2+)-ATPase
isoform 4 and analysis of alternative splicing patterns at splice site A, Biochem. J.
306 (Pt. 3) (1995) 779–785.
[49] E. Carafoli, T. Stauffer, The plasma membrane calcium pump: functional domains,
regulation of the activity and tissue speciﬁcity of isoform expression, J. Neurobiol.
25 (1994) 312–324.
[50] P. Brandt, R.L. Neve, Expression of plasma membrane calcium-pumping ATPase
mRNAs in developing rat brain and adult brain subregions: evidence for stage-
speciﬁc expression, J. Neurochem. 59 (1992) 1566–1569.
[51] D.A. Zacharias, E.E. Strehler, Change inplasmamembraneCa2+-ATPase splice-variant
expression in response to a rise in intracellular Ca2+, Curr. Biol. 6 (1996) 1642–1652.
[52] S. Stamm, Regulation of alternative splicing by reversible protein phosphorylation,
J. Biol. Chem. 283 (2008) 1223–1227.
[53] D. Guerini, E. Garcia-Martin, A. Gerber, C. Volbracht, M. Leist, C. Gutiérrez-Merino,
E. Carafoli, The expression of plasma membrane Ca2+ pump in cerebellar granule
neurons is modulated by Ca2+, J. Biol. Chem. 274 (1999) 1667–1676.
[54] H. Hilﬁker, D. Guerini, E. Carafoli, Cloning and expression of isoform 2 of the
human plasma membrane Ca2+ ATPase. Functional properties of the enzyme and
ist splicing products. J. Biol. Chem. 269 (1994) 26178–26183.
[55] A. Enyedi, A.K. Verma, R. Heim, H.P. Adamo, A.G. Filoteo, E.E. Strehler, J.P.
Penniston, The Ca2+ afﬁnity of the plasma membrane Ca2+ pump is controlled by
alternative splicing, J. Biol. Chem. 269 (1994) 41–43.
[56] B.S. Preiano', D. Guerini, E. Carafoli, Expression and functional characterization of iso-
forms 4 of the plasma membrane calcium pump, Biochemistry 35 (1996) 7946–7953.
[57] A.J. Caride, A.G. Filoteo, J.T. Penniston, E.E. Strehler, The plasma membrane Ca2+
pump isoform 4a differs from isoform 4b in the mechanism of calmodulin bindingand activation kinetics. Implications for Ca2+ signaling, J. Biol. Chem. 282 (2007)
25640–25648.
[58] P.J. Shepard, K.J. Hertel, Conserved RNA secondary structures promote alternative
splicing, RNA 14 (2008) 1463–1469.
[59] C.A. Ohmstede, K.F. Jensen, N.E. Sahyoun, Ca2+/calmodulin-dependent protein
kinase enriched in cerebellar granule cells. Identiﬁcation of a novel neuronal
calmodulin-dependent protein kinase. J. Biol. Chem. 264 (1989) 5866–5875.
[60] P. Vito, E. Lacana, L. D'Adamio, Interfering with apoptosis: Ca(2+)-binding protein
ALG-2 and Alzheimer's disease gene ALG-3, Science 271 (1996) 521–525.
[61] M. Maki, S.V.L. Narayana, K. Hitomi, A growing family of the Ca2+-binding
proteins with ﬁve EF-hand motifs, Biochem. J. 328 (1997) 718–720.
[62] J. Krebs, R. Klemenz, The ALG-2/AIP-complex, a modulator at the interface
between cell proliferation and cell death? A hypothesis, Biochim. Biophys. Acta
1498 (2000) 153–161.
[63] J. Krebs, P. Saremaslani, R. Caduff, ALG-2: a Ca2+-binding modulator protein
involved in cell proliferation and in cell death, Biochim. Biophys. Acta 1600 (2002)
68–73.
[64] Y. Kitaura, S. Matsumoto, H. Satoh, K. Hitomi, M. Maki, Peﬂin and ALG-2, members
of the penta-EF-hand protein family, form a heterodimer that dissociates in a
Ca2+-dependent manner, J. Biol. Chem. 276 (2001) 14053–14058.
[65] P. Montaville, Y. Dai, C.Y. Cheung, K. Giller, S. Becker, M. Michalak, S.E. Webb, A.L.
Miller, J. Krebs, Nuclear translocation of the calcium-binding protein ALG-2
induced by the RNA-binding protein RBM22, Biochim. Biophys. Acta 1763 (2006)
1335–1343.
[66] L. Subramanian, J.W. Crabb, J. Cox, I. Durussel, T.M. Walker, P.R. van Ginkel, S.
Bhattacharya, J.M. Dellaria, K. Palczewski, A.S. Polans, Ca2+ binding to EF hands 1
and 3 is essential for the interaction of apoptosis-linked gene-2 with Alix/AIP1 in
ocular melanoma, Biochemistry 43 (2004) 11175–11186.
[67] K. Hartmuth, H. Urlaub, H.P. Vornlocher, C.L. Will, M. Gentzel, M. Wilm, R.
Luhrmann, Protein composition of human prespliceosomes isolated by a
tobramycin afﬁnity-selection method, Proc. Natl. Acad. Sci. U. S. A. 99 (2002)
16719–16724.
[68] J. Rappsilber, U. Ryder, A.I. Lamond, M.Mann, Large-scale proteomic analysis of the
human spliceosome, Genome Res. 12 (2002) 1231–1245.
[69] J.W. Park, K. Parisky, A.M. Celotto, R.A. Reenan, B.R. Graveley, Identiﬁcation of
alternative splicing regulators by RNA interference in Drosophila, Proc. Natl. Acad.
Sci. U. S. A. 101 (2004) 15974–15979.
[70] Y.O. Kim, S.J. Park, R.S. Balaban, M. Nirenberg, Y. Kim, A functional genomic screen
for cardiogenic genes using RNA interference in developing Drosophila embryos,
Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 159–164.
[71] A. Amsterdam, R.M. Nissen, Z. Sun, E.C. Swindell, S. Farrington, N. Hopkins,
Identiﬁcation of 315 genes essential for early zebraﬁsh development, Proc. Natl.
Acad. Sci. U. S. A. 101 (2004) 12792–12797.
[72] R. Kittler, G. Putz, L. Pelletier, I. Poser, A.K. Heninger, D. Drechsel, S. Fischer, I.
Konstantinova, B. Habermann, H. Grabner, M.L. Yaspo, H. Himmelbauer, B. Korn, K.
Neugebauer, M.T. Pisabarro, F. Buchholz, An endoribonuclease-prepared siRNA
screen in human cells identiﬁes genes essential for cell division, Nature 432
(2004) 1036–1040.
[73] D.L. Spector, Macromolecular domains within the cell nucleus, Annu. Rev. Cell.
Biol. 9 (1993) 265–315.
[74] A.I. Lamond, D.L. Spector, Nuclear speckles: a model for nuclear organelles, Nat.
Rev. Mol. Cell Biol. 4 (2003) 605–612.
[75] M. Alvarez, X. Estivill, S. de la Luna, DYRK1A accumulates in splicing speckles
through a novel targeting signal and induces speckle disassembly, J. Cell Sci. 116
(2003) 3099–3107.
[76] K.E. Handwerger, J.G. Gall, Subnuclear organelles: new insights into form and
function, Trends Cell. Biol. 16 (2006) 19–26.
